FI89047C - Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-tioner - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-tioner

Info

Publication number
FI89047C
FI89047C FI864377A FI864377A FI89047C FI 89047 C FI89047 C FI 89047C FI 864377 A FI864377 A FI 864377A FI 864377 A FI864377 A FI 864377A FI 89047 C FI89047 C FI 89047C
Authority
FI
Finland
Prior art keywords
triazole
diethyl
aryl
ions
preparation
Prior art date
Application number
FI864377A
Other languages
English (en)
Swedish (sv)
Other versions
FI864377A0 (fi
FI89047B (fi
FI864377A (fi
Inventor
John M Kane
Francis P Miller
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI864377A0 publication Critical patent/FI864377A0/fi
Publication of FI864377A publication Critical patent/FI864377A/fi
Application granted granted Critical
Publication of FI89047B publication Critical patent/FI89047B/fi
Publication of FI89047C publication Critical patent/FI89047C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI864377A 1985-10-29 1986-10-28 Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-tioner FI89047C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US79235985A 1985-10-29 1985-10-29
US79235985 1985-10-29
US80761385A 1985-12-11 1985-12-11
US80761385 1985-12-11

Publications (4)

Publication Number Publication Date
FI864377A0 FI864377A0 (fi) 1986-10-28
FI864377A FI864377A (fi) 1987-04-30
FI89047B FI89047B (fi) 1993-04-30
FI89047C true FI89047C (fi) 1993-08-10

Family

ID=27121269

Family Applications (1)

Application Number Title Priority Date Filing Date
FI864377A FI89047C (fi) 1985-10-29 1986-10-28 Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-tioner

Country Status (19)

Country Link
EP (1) EP0221485B1 (fi)
JP (1) JPH07116162B2 (fi)
KR (1) KR900003879B1 (fi)
CN (1) CN1014993B (fi)
AR (1) AR243171A1 (fi)
AU (1) AU587646B2 (fi)
CA (2) CA1284997C (fi)
DE (1) DE3676632D1 (fi)
DK (1) DK164785C (fi)
ES (1) ES2031449T3 (fi)
FI (1) FI89047C (fi)
GR (1) GR3001246T3 (fi)
HU (1) HU196191B (fi)
IE (1) IE58969B1 (fi)
IL (1) IL80434A (fi)
NO (1) NO165542C (fi)
NZ (1) NZ218087A (fi)
PH (2) PH22377A (fi)
PT (1) PT83636B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR243169A1 (es) * 1985-10-29 1993-07-30 Merrell Pharma Inc Procedimiento para preparar 5-naftil-2,4-dialquil-3h-1,2,4-triazol-3-tionas.
JP2593084B2 (ja) * 1986-12-19 1997-03-19 メレルダウファーマスーティカルズ インコーポレーテッド ５−アリールー３ｈ−１，２，４−トリアゾールー３−オン類の神経変性障害の処置への用途
JP2542880B2 (ja) * 1986-12-19 1996-10-09 メレルダウファーマスーティカルズ インコーポレーテッド ５−アリ―ル−３ｈ−１，２，４，−トリアゾ―ル−３−オン類の抗痙攣剤としての用途
EP0280867A1 (en) * 1987-01-27 1988-09-07 Merrell Dow Pharmaceuticals Inc. Process for the preparation of 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones
US4847276A (en) * 1988-09-06 1989-07-11 Merrell Dow Pharmaceuticals Inc. Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione
AU679130B2 (en) * 1993-10-29 1997-06-19 Aventis Inc. 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles useful as memory enhancers
CA2193800C (en) * 1994-07-07 1999-03-16 Sandra K. Stolz-Dunn Process for the preparation of 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR243169A1 (es) * 1985-10-29 1993-07-30 Merrell Pharma Inc Procedimiento para preparar 5-naftil-2,4-dialquil-3h-1,2,4-triazol-3-tionas.
DK570987A (da) * 1986-12-01 1988-06-02 Hoffmann La Roche Oxadiazol-, thiadiazol- og triazolforbindelser

Also Published As

Publication number Publication date
DK164785C (da) 1992-12-28
IE862832L (en) 1987-04-29
JPS62106085A (ja) 1987-05-16
EP0221485B1 (en) 1990-12-27
PT83636A (en) 1986-11-01
NO864306D0 (no) 1986-10-28
NZ218087A (en) 1989-05-29
CA1301655C (en) 1992-05-26
CN86106880A (zh) 1987-06-10
DK514886A (da) 1987-04-30
DK514886D0 (da) 1986-10-28
NO165542B (no) 1990-11-19
IL80434A0 (en) 1987-01-30
NO165542C (no) 1991-02-27
PH22377A (en) 1988-08-12
JPH07116162B2 (ja) 1995-12-13
IL80434A (en) 1991-01-31
AU6438686A (en) 1987-04-30
FI864377A0 (fi) 1986-10-28
HU196191B (en) 1988-10-28
PH23275A (en) 1989-06-23
IE58969B1 (en) 1993-12-01
CN1014993B (zh) 1991-12-04
AU587646B2 (en) 1989-08-24
KR900003879B1 (ko) 1990-06-04
CA1284997C (en) 1991-06-18
FI89047B (fi) 1993-04-30
DE3676632D1 (de) 1991-02-07
AR243171A1 (es) 1993-07-30
FI864377A (fi) 1987-04-30
ES2031449T3 (es) 1992-12-16
PT83636B (pt) 1988-10-14
GR3001246T3 (en) 1992-07-30
KR870004006A (ko) 1987-05-06
DK164785B (da) 1992-08-17
HUT45030A (en) 1988-05-30
NO864306L (no) 1987-04-30
EP0221485A1 (en) 1987-05-13

Similar Documents

Publication Publication Date Title
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI90769C (fi) Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
FI892881A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminohappojohdannaisten va lmistamiseksi
FI882007A (fi) Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
FI94752C (fi) Menetelmä terapeuttisesti käyttökelpoisten propenonioksiimieettereiden valmistamiseksi
FI881303A0 (fi) Menetelmä ibuprofeenin valmistamiseksi
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI873350A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI103727B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-amino-4-substioitu-fenyyli-4H-pyrano[3,2-h]kinoliini-3-karbonitriilien valmistamiseksi
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI92205C (fi) Menetelmä terapeuttisesti käyttökelpoisten N-pyrrolo- ja pyrido /3,2,1,-j k/ /1,4/ bentsodiatsepinyyli-N'-aryyliurea ja tioureajohdannaisten valmistamiseksi
FI920933A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI911701A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
FI89047C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-tioner
FI901883A0 (fi) Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI89062C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara somatostatinanaloger
FI900145A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI91526B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
FI892144A (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
FI893121A (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.